Siga Technologies INC Restricted Cash and Investments, Current
Siga Technologies INC (SIGA) had Restricted Cash and Investments, Current of $0 as of 2015-09-30, per its 10-Q filed 2015-10-27.
Discontinued › Balance Sheet › Assets › Assets, Current › Restricted Cash and Investments, Current
us-gaap:RestrictedCashAndInvestmentsCurrent · last filed 2015-10-27
- 2015-09-30: Restricted Cash and Investments, Current $0.00.
- 2015-06-30: Restricted Cash and Investments, Current $0.00.
- 2015-03-31: Restricted Cash and Investments, Current $0.00.
- 2014-12-31: Restricted Cash and Investments, Current $4.00M.
| Period end | Restricted Cash and Investments, Current |
|---|---|
| 2015-09-30 | $0.00 10-Q · filed 2015-10-27 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-04 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-06 |
| 2014-12-31 | $4.00M 10-Q · filed 2015-10-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |